Talkspace Announces Second Quarter 2024 Results
Talkspace (NASDAQ: TALK) reported strong Q2 2024 results, with total revenue growing 29% year-over-year to $46.1 million. This growth was primarily driven by a 62% increase in Payor revenue and a 20% rise in Direct to Enterprise revenue. The company's net loss significantly improved to $0.5 million from $4.7 million in the previous year. Adjusted EBITDA turned positive at $1.2 million, compared to a loss of $4.0 million in Q2 2023.
Key highlights include:
- Expanded covered lives to over 145 million
- Launched Medicare offering in 12 states
- Approved additional $25 million share repurchase program
- Maintained fiscal year 2024 revenue guidance of $185-$195 million
- Adjusted EBITDA guidance of $4-$8 million for FY 2024
Talkspace (NASDAQ: TALK) ha riportato risultati solidi per il secondo trimestre del 2024, con un fatturato totale che è cresciuto del 29% rispetto all'anno precedente, raggiungendo i 46,1 milioni di dollari. Questa crescita è stata principalmente guidata da un aumento del 62% delle entrate da Payor e da un incremento del 20% delle entrate Dirette per le Imprese. La perdita netta dell'azienda è migliorata significativamente, passando da 4,7 milioni di dollari dell'anno scorso a 0,5 milioni di dollari. L'EBITDA rettificato è diventato positivo, raggiungendo 1,2 milioni di dollari, rispetto a una perdita di 4 milioni di dollari nel secondo trimestre del 2023.
I principali punti salienti includono:
- Espansione della copertura a oltre 145 milioni di vite
- Avvio dell'offerta Medicare in 12 stati
- Approvato un programma aggiuntivo di riacquisto di azioni da 25 milioni di dollari
- Mantenuta la previsione di fatturato per l'anno fiscale 2024 tra 185 e 195 milioni di dollari
- Previsione di EBITDA rettificato tra 4 e 8 milioni di dollari per l'anno fiscale 2024
Talkspace (NASDAQ: TALK) reportó resultados sólidos para el segundo trimestre de 2024, con ingresos totales que crecieron un 29% interanual, alcanzando los 46,1 millones de dólares. Este crecimiento fue impulsado principalmente por un aumento del 62% en los ingresos de Payor y un incremento del 20% en los ingresos directos a empresas. La pérdida neta de la compañía mejoró significativamente, disminuyendo de 4,7 millones de dólares del año anterior a 0,5 millones de dólares. El EBITDA ajustado se volvió positivo con 1,2 millones de dólares, en comparación con una pérdida de 4 millones de dólares en el segundo trimestre de 2023.
Los aspectos destacados incluyen:
- Expansión de la cobertura a más de 145 millones de vidas
- Lanzamiento de la oferta de Medicare en 12 estados
- Autorizado un programa adicional de recompra de acciones de 25 millones de dólares
- Manteniendo la guía de ingresos para el año fiscal 2024 entre 185 y 195 millones de dólares
- Guía de EBITDA ajustado de entre 4 y 8 millones de dólares para el año fiscal 2024
Talkspace (NASDAQ: TALK)는 2024년 2분기 강력한 실적을 발표했습니다. 총 수익이 전년 대비 29% 증가하여 4,610만 달러에 달했습니다. 이 성장은 주로 Payor 수익이 62% 증가하고 엔터프라이즈 직접 수익이 20% 증가한 데 힘입은 것입니다. 회사의 순손실은 작년의 470만 달러에서 50만 달러로 크게 개선되었습니다. 조정 EBITDA는 120만 달러로 긍정적으로 전환되었으며, 이는 2023년 2분기에서 400만 달러의 손실과 비교됩니다.
주요 하이라이트는 다음과 같습니다:
- 보장된 생명이 1억 4,500만 이상으로 확대됨
- 12개 주에서 Medicare 제공 시작
- 2,500만 달러의 추가 자사주 매입 프로그램 승인
- 2024 회계 연도 수익 가이던스 1억 8,500만 - 1억 9,500만 달러 유지
- 2024 회계 연도 조정 EBITDA 가이던스 400만 - 800만 달러
Talkspace (NASDAQ: TALK) a rapporté de solides résultats pour le deuxième trimestre de 2024, avec un chiffre d'affaires total en hausse de 29 % par rapport à l'année précédente, atteignant 46,1 millions de dollars. Cette croissance a été principalement soutenue par une augmentation de 62 % des revenus Payor et une hausse de 20 % des revenus directs aux entreprises. La perte nette de l'entreprise s'est considérablement améliorée, passant de 4,7 millions de dollars l'année précédente à 0,5 million de dollars. L'EBITDA ajusté est devenu positif avec 1,2 million de dollars, contre une perte de 4 millions de dollars au deuxième trimestre de 2023.
Les points saillants incluent :
- Extension de la couverture à plus de 145 millions de vies
- Lancement de l'offre Medicare dans 12 états
- Approbation d'un programme de rachat d'actions supplémentaire de 25 millions de dollars
- Maintien des prévisions de revenus pour l'exercice 2024 entre 185 et 195 millions de dollars
- Prévisions d'EBITDA ajusté de 4 à 8 millions de dollars pour l'exercice 2024
Talkspace (NASDAQ: TALK) hat im zweiten Quartal 2024 starke Ergebnisse berichtet, wobei der Gesamtumsatz im Vergleich zum Vorjahr um 29% auf 46,1 Millionen Dollar gewachsen ist. Dieses Wachstum wurde hauptsächlich durch einen Anstieg der Payor-Einnahmen um 62% und einen Anstieg der direkten Unternehmenseinnahmen um 20% getrieben. Der Nettoverlust des Unternehmens hat sich signifikant von 4,7 Millionen Dollar im Vorjahr auf 0,5 Millionen Dollar verbessert. Das bereinigte EBITDA wurde positiv und belief sich auf 1,2 Millionen Dollar, verglichen mit einem Verlust von 4 Millionen Dollar im zweiten Quartal 2023.
Wichtige Highlights sind:
- Erweiterte Versicherte auf über 145 Millionen Menschen
- Medicare-Angebot in 12 Bundesstaaten gestartet
- Zusätzliches Aktienrückkaufprogramm über 25 Millionen Dollar genehmigt
- Fiskalische Umsatzprognose für das Jahr 2024 von 185 bis 195 Millionen Dollar beibehalten
- Bereinigte EBITDA-Prognose von 4 bis 8 Millionen Dollar für das Geschäftsjahr 2024
- Total revenue grew 29% year-over-year to $46.1 million
- Payor revenue increased 62% year-over-year
- Direct to Enterprise revenue rose 20% year-over-year
- Net loss improved to $0.5 million from $4.7 million in Q2 2023
- Adjusted EBITDA turned positive at $1.2 million
- Expanded covered lives to over 145 million
- Launched Medicare offering in 12 states
- Approved additional $25 million share repurchase program
- Consumer revenue declined 28% year-over-year
- Gross margin declined to 45.5% from 50% in the prior-year period
- Operating expenses increased 1% year-over-year
Insights
Talkspace's Q2 2024 results show significant progress towards profitability. Total revenue grew 29% year-over-year to
The shift in revenue mix towards Payor led to a slight decline in gross margin to
Talkspace's Q2 results reflect strong market penetration and strategic positioning. The company expanded its covered lives to over 145 million, a
However, the
Talkspace's Q2 performance underscores the growing demand for accessible mental health services. The
The launch of Medicare offerings in 12 states is a strategic move to tap into the growing senior mental health market. However, the decline in Consumer active members suggests potential saturation or increased competition in the direct-to-consumer segment. Talkspace's ability to optimize marketing efforts and differentiate its product quality will be key to maintaining its growth trajectory in both B2B and B2C segments.
2Q 2024 Total revenue grew
year-over-year growth in Payor revenue
Reduced GAAP Net loss to
2Q 2024 Adjusted EBITDA1 of
Board approved an additional
NEW YORK, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Talkspace, Inc. (“Talkspace” or the “Company”) (NASDAQ: TALK), today reported second quarter 2024 financial results.
Three Months | Six Months | |||||||||||||
June 30, 2024 (Unaudited) | Results | % Variance from Prior Year | Results | % Variance from Prior Year | ||||||||||
(In thousands unless otherwise noted) | ||||||||||||||
Number of eligible lives at period end (in millions) | 145.3 | 33 | % | 145.3 | 33 | % | ||||||||
Number of completed Payor sessions | 298.6 | 49 | % | 582.8 | 57 | % | ||||||||
Number of Consumer active members at period end | 10.7 | (22 | )% | 10.7 | (22 | )% | ||||||||
Total revenue | $ | 46,058 | 29 | % | $ | 91,474 | 33 | % | ||||||
Gross profit | $ | 20,951 | 18 | % | $ | 42,682 | 24 | % | ||||||
Gross margin % | ||||||||||||||
Operating expenses | $ | 24,437 | 1 | % | $ | 47,847 | (4 | )% | ||||||
Net loss | $ | (474 | ) | 90 | % | $ | (1,940 | ) | 86 | % | ||||
Adjusted EBITDA1 | $ | 1,179 | 130 | % | $ | 1,953 | 119 | % | ||||||
Cash and cash equivalents at period end | $ | 114,913 | — | $ | 114,913 | — | ||||||||
(1) Adjusted EBITDA is a non-GAAP financial measure. For a definition of the measure and a reconciliation to the most direct comparable GAAP measure, see “Reconciliation of Non-GAAP Results to GAAP Results.” | ||||||||||||||
“Our robust second quarter performance reflects continued business execution, resulting in
Dr. Cohen added, “This positive momentum stems from our ongoing commitment to enhancing both provider experience and patient journey, while focusing on product quality - key differentiators for Talkspace. I’m encouraged by our results, which underscore our dedication to making high-quality mental health care more accessible.”
Second Quarter 2024 Key Performance Metrics
- Revenue increased
29% over the prior-year period to$46.1 million , driven by a62% year-over-year increase in Payor revenue and a20% year-over-year increase in Direct to Enterprise (“DTE”) revenue; partially offset by a28% year-over-year Consumer revenue decline. - Gross profit increased
18% over the prior-year period to$21 million , and gross margin declined to45.5% from50% in the prior-year period, driven by a shift in revenue mix towards Payor. - Operating expenses were
$24.4 million , an increase of1% year-over-year, driven primarily by higher general and administrative expenses. - Net loss was
$(0.5) million , an improvement from$(4.7) million net loss in the second quarter of 2023, primarily driven by an increase in revenues, partially offset by an increase in cost of revenues. - Adjusted EBITDA was
$1.2 million , an improvement from$(4.0) million in the second quarter of 2023, primarily driven by an increase in revenues, partially offset by an increase in cost of revenues.
Financial Guidance
Talkspace continues to expect fiscal year 2024 revenue to be in the range of
Share Repurchase Program
During the second quarter of 2024, Talkspace repurchased
Conference Call, Presentation Slides, and Webcast Details
The Second Quarter 2024 earnings conference call and webcast will be held Tuesday, August 6, 2024, at 8:30 a.m. E.T. The conference call will be available via audio webcast at investors.talkspace.com and can also be accessed by dialing (888) 330-2391 for U.S. participants, or +1 (240) 789-2702 for international participants, and referencing participant code 2348878. A replay will be available shortly after the call’s completion and remain available for approximately 90 days.
About Talkspace
Talkspace (NASDAQ: TALK) is a leading virtual behavioral healthcare provider committed to helping people lead healthier, happier lives through access to high-quality mental healthcare. At Talkspace, we believe that mental healthcare is core to overall health and should be available to everyone.
Talkspace pioneered the ability to text with a licensed therapist from anywhere and now offers a comprehensive suite of mental health services, including therapy for individuals, teens, and couples, as well as psychiatric treatment and medication management (18+). With Talkspace’s core therapy offerings, members are matched with one of thousands of licensed therapists within days and can engage in live video, audio, or chat sessions, and/or unlimited asynchronous text messaging sessions.
All care offered at Talkspace is delivered through an easy-to-use, fully-encrypted web and mobile platform that meets HIPAA, federal, and state regulatory requirements. More than 151 million Americans have access to Talkspace through their health insurance plans, employee assistance programs, our partnerships with leading healthcare companies, or as a free benefit through their employer, school, or government agency.
For more information, visit www.talkspace.com.
For Investors:
ICR Westwicke
TalkspaceIR@westwicke.com
For Media:
John Kim
SKDK
(310) 997-5963
jkim@skdknick.com
Forward Looking Statements
This press release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking, including statements regarding our financial condition, anticipated financial performance, achieving profitability, business strategy and plans, market opportunity and expansion and objectives of our management for future operations. These forward-looking statements generally are identified by the words “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “forecast”, “future”, “intend,” “may,” “might”, “opportunity”, “plan,” “possible”, “potential,” “predict,” “project,” “should,” “strategy”, “strive”, “target,” “will,” or “would”, the negative of these words or other similar terms or expressions. The absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many important factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to factors and the other risks and uncertainties described under the caption “Risk Factors” in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on March 13, 2024, subsequent quarterly reports on Form 10-Q and our other documents filed from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and we assume no obligation and do not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise unless required to do so under applicable law. We do not give any assurance that we will achieve our expectations.
Talkspace, Inc. Condensed Consolidated Statements of Operations | ||||||||||||||||||||||||
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||
2024 | 2023 | % Change | 2024 | 2023 | % Change | |||||||||||||||||||
(in thousands, except percentages, share and per share data) | Unaudited | Unaudited | Unaudited | Unaudited | ||||||||||||||||||||
Revenue: | ||||||||||||||||||||||||
Payor revenue | $ | 29,945 | $ | 18,539 | 61.5 | $ | 58,453 | $ | 33,350 | 75.3 | ||||||||||||||
DTE revenue | 9,628 | 8,039 | 19.8 | 19,541 | 16,715 | 16.9 | ||||||||||||||||||
Consumer revenue | 6,485 | 9,067 | (28.5 | ) | 13,480 | 18,916 | (28.7 | ) | ||||||||||||||||
Total revenue | 46,058 | 35,645 | 29.2 | 91,474 | 68,981 | 32.6 | ||||||||||||||||||
Cost of revenues | 25,107 | 17,833 | 40.8 | 48,792 | 34,421 | 41.8 | ||||||||||||||||||
Gross profit | 20,951 | 17,812 | 17.6 | 42,682 | 34,560 | 23.5 | ||||||||||||||||||
Operating expenses: | ||||||||||||||||||||||||
Research and development | 2,163 | 4,171 | (48.1 | ) | 5,902 | 9,524 | (38.0 | ) | ||||||||||||||||
Clinical operations, net | 1,661 | 1,675 | (0.8 | ) | 3,125 | 3,276 | (4.6 | ) | ||||||||||||||||
Sales and marketing | 13,269 | 13,045 | 1.7 | 26,278 | 26,514 | (0.9 | ) | |||||||||||||||||
General and administrative | 7,344 | 5,329 | 37.8 | 12,542 | 10,693 | 17.3 | ||||||||||||||||||
Total operating expenses | 24,437 | 24,220 | 0.9 | 47,847 | 50,007 | (4.3 | ) | |||||||||||||||||
Operating loss | (3,486 | ) | (6,408 | ) | 45.6 | (5,165 | ) | (15,447 | ) | 66.6 | ||||||||||||||
Financial (income), net | (3,044 | ) | (1,712 | ) | 77.8 | (3,422 | ) | (2,136 | ) | 60.2 | ||||||||||||||
Loss before taxes on income | (442 | ) | (4,696 | ) | 90.6 | (1,743 | ) | (13,311 | ) | 86.9 | ||||||||||||||
Taxes on income | 32 | 8 | 300.0 | 197 | 151 | 30.5 | ||||||||||||||||||
Net loss | $ | (474 | ) | $ | (4,704 | ) | 89.9 | $ | (1,940 | ) | $ | (13,462 | ) | 85.6 | ||||||||||
Net loss per share: | ||||||||||||||||||||||||
Basic and Diluted | $ | (0.00 | ) | $ | (0.03 | ) | 90.0 | $ | (0.01 | ) | $ | (0.08 | ) | 87.5 | ||||||||||
Weighted average number of common shares: | ||||||||||||||||||||||||
Basic and Diluted | 169,148,522 | 164,195,697 | 168,997,734 | 163,003,363 |
Talkspace, Inc. Condensed Consolidated Balance Sheets | ||||||||
June 30, 2024 | December 31, 2023 | |||||||
(in thousands) | Unaudited | |||||||
ASSETS | ||||||||
CURRENT ASSETS: | ||||||||
Cash and cash equivalents | $ | 114,913 | $ | 123,908 | ||||
Accounts receivable, net | 11,554 | 10,174 | ||||||
Other current assets | 2,302 | 5,718 | ||||||
Total current assets | 128,769 | 139,800 | ||||||
Other long-term assets | 5,021 | 2,421 | ||||||
Total assets | $ | 133,790 | $ | 142,221 | ||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||
CURRENT LIABILITIES: | ||||||||
Accounts payable | $ | 7,733 | $ | 6,111 | ||||
Deferred revenues | 2,733 | 3,069 | ||||||
Accrued expenses and other current liabilities | 7,313 | 12,468 | ||||||
Total current liabilities | 17,779 | 21,648 | ||||||
Warrant liabilities | 1,332 | 1,842 | ||||||
Other liabilities | 635 | 85 | ||||||
Total liabilities | 19,746 | 23,575 | ||||||
STOCKHOLDERS’ EQUITY: | ||||||||
Common stock | 16 | 16 | ||||||
Additional paid-in capital | 386,352 | 389,014 | ||||||
Accumulated deficit | (272,324 | ) | (270,384 | ) | ||||
Total stockholders’ equity | 114,044 | 118,646 | ||||||
Total liabilities and stockholders’ equity | $ | 133,790 | $ | 142,221 |
Talkspace, Inc. Condensed Consolidated Statements of Cash Flows | ||||||||
Six Months Ended June 30, | ||||||||
2024 | 2023 | |||||||
(in thousands) | Unaudited | Unaudited | ||||||
Cash flows from operating activities: | ||||||||
Net loss | $ | (1,940 | ) | $ | (13,462 | ) | ||
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
Depreciation and amortization | 421 | 608 | ||||||
Stock-based compensation | 5,359 | 4,432 | ||||||
Remeasurement of warrant liabilities | (510 | ) | (119 | ) | ||||
(Increase) decrease in accounts receivable | (1,380 | ) | 1,220 | |||||
Decrease in other current assets | 3,416 | 1,452 | ||||||
Increase (decrease) in accounts payable | 1,622 | (977 | ) | |||||
Decrease in deferred revenues | (336 | ) | (672 | ) | ||||
Decrease in accrued expenses and other current liabilities | (5,155 | ) | (6,058 | ) | ||||
Other | (79 | ) | (172 | ) | ||||
Net cash provided by (used in) operating activities | 1,418 | (13,748 | ) | |||||
Cash flows from investing activities: | ||||||||
Capitalized internal-use software costs | (2,110 | ) | — | |||||
Purchase of computer and equipment | (40 | ) | (10 | ) | ||||
Other | — | 28 | ||||||
Net cash (used in) provided by investing activities | (2,150 | ) | 18 | |||||
Cash flows from financing activities: | ||||||||
Proceeds from exercise of stock options | 1,584 | 1,490 | ||||||
Payments for employee taxes withheld related to vested stock-based awards | (1,843 | ) | (201 | ) | ||||
Repurchase and cancellation of common stock | (8,004 | ) | — | |||||
Net cash (used in) provided by financing activities | (8,263 | ) | 1,289 | |||||
Net decrease in cash and cash equivalents | (8,995 | ) | (12,441 | ) | ||||
Cash and cash equivalents at the beginning of the period | 123,908 | 138,545 | ||||||
Cash and cash equivalents at the end of the period | $ | 114,913 | $ | 126,104 |
Non-GAAP Financial Measures
In addition to our financial results determined in accordance with GAAP, we believe adjusted EBITDA, a non-GAAP measure, is useful in evaluating our operating performance, and our management uses it as a key performance measure to assess our operating performance. Because adjusted EBITDA facilitates internal comparisons of our historical operating performance on a more consistent basis, we use this measure for business planning purposes and in evaluating acquisition opportunities. We also use adjusted EBITDA to evaluate our ongoing operations and for internal planning and forecasting purposes. We believe that this non-GAAP financial measure, when taken together with the corresponding GAAP financial measures, provides meaningful supplemental information regarding our performance by excluding certain items that may not be indicative of our business, results of operations or outlook. We believe that the use of adjusted EBITDA is helpful to our investors as it is a metric used by management in assessing the health of our business and our operating performance. However, non-GAAP financial information is presented for supplemental informational purposes only, has limitations as an analytical tool and should not be considered in isolation or as a substitute for financial information presented in accordance with GAAP.
Some of the limitations of adjusted EBITDA include (i) adjusted EBITDA does not necessarily reflect capital commitments to be paid in the future and (ii) although depreciation and amortization are non-cash charges, the underlying assets may need to be replaced and adjusted EBITDA does not reflect these requirements. In evaluating adjusted EBITDA, you should be aware that in the future we will incur expenses similar to the adjustments described herein. Our presentation of adjusted EBITDA should not be construed as an inference that our future results will be unaffected by these expenses or any unusual or non-recurring items. Our adjusted EBITDA may not be comparable to similarly titled measures of other companies because they may not calculate adjusted EBITDA in the same manner as we calculate the measure, limiting its usefulness as a comparative measure. Adjusted EBITDA should not be considered as an alternative to loss before income taxes, net loss, loss per share, or any other performance measures derived in accordance with U.S. GAAP. When evaluating our performance, you should consider adjusted EBITDA alongside other financial performance measures, including our net loss and other GAAP results.
A reconciliation is provided below for adjusted EBITDA to net loss, the most directly comparable financial measure stated in accordance with GAAP. Investors are encouraged to review our financial statements prepared in accordance with GAAP and the reconciliation of our non-GAAP financial measure to its most directly comparable GAAP financial measure, and not to rely on any single financial measure to evaluate our business. We do not provide a forward-looking reconciliation of adjusted EBITDA guidance as the amount and significance of the reconciling items required to develop meaningful comparable GAAP financial measures cannot be estimated at this time without unreasonable efforts. These reconciling items could be meaningful.
Adjusted EBITDA
We calculate adjusted EBITDA as net loss adjusted to exclude (i) depreciation and amortization, (ii) interest and other expenses (income), net, (iii) tax benefit and expense, (iv) stock-based compensation expense, and (v) certain non-recurring expenses, where applicable.
Talkspace, Inc. Reconciliation of Non-GAAP Results to GAAP Results | ||||||||||||||||
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||
2024 | 2023 | 2024 | 2023 | |||||||||||||
(in thousands) | Unaudited | Unaudited | Unaudited | Unaudited | ||||||||||||
Net loss | $ | (474 | ) | $ | (4,704 | ) | $ | (1,940 | ) | $ | (13,462 | ) | ||||
Add: | ||||||||||||||||
Depreciation and amortization | 220 | 302 | 421 | 608 | ||||||||||||
Financial (income), net (1) | (3,044 | ) | (1,712 | ) | (3,422 | ) | (2,136 | ) | ||||||||
Taxes on income | 32 | 8 | 197 | 151 | ||||||||||||
Stock-based compensation | 3,107 | 2,129 | 5,359 | 4,432 | ||||||||||||
Non-recurring expenses (2) | 1,338 | — | 1,338 | — | ||||||||||||
Adjusted EBITDA | $ | 1,179 | $ | (3,977 | ) | $ | 1,953 | $ | (10,407 | ) | ||||||
(1) For the three months ended June 30, 2024 and 2023, financial (income), net, primarily consisted of (2) For the three and six months ended June 30, 2024, non-recurring expenses, primarily consisted of severance costs related to the departure of key executives of Talkspace and other related costs. | ||||||||||||||||
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/74a7505e-f12a-4d68-a3ff-716ecd785f0f
FAQ
What was Talkspace's revenue growth in Q2 2024?
How did Talkspace's net loss change in Q2 2024 compared to the previous year?
What is Talkspace's revenue guidance for fiscal year 2024?
How many covered lives does Talkspace have as of Q2 2024?